Arriving in the landscape of excess body fat management, retatrutide represents a different method. Unlike many available medications, retatrutide operates as a dual agonist, at once targeting both glucagon-like peptide-1 (GLP-1) and glucose-responsive insulinotropic substance (GIP) binding sites. The concurrent activation encourages various helpfu… Read More